Study investigated the prognostic signifigance of CXCR4 mutations to determine outcomes of Waldenstrom Macroglobulinemia treated with Ibrutinib.
Home / Resource Library / CXCR4 clonality is an important determinant of ibrutinib outcomes in patients with Waldenstrom Macroglobulinemia